🇮🇳

Index Intelligence

· daily

BSE FMCG Sector Regulatory Filings — November 05, 2026

The 18 filings cover S&P BSE FMCG constituents dated 2026-11-05, dominated by Q2 FY27 results cycles from Emami, Dabur, Britannia, United Spirits and Marico, plus Varun Beverages. Headline top-line growth was strong: Emami consolidated revenue rose 36.2% YoY to ₹1,08,765 Lacs (helped by Axiom Ayurveda and IncNut Digital acquisitions), Britannia consolidated revenue rose roughly 15.6% YoY to ₹5,597.79 Crore with 13% volume growth, and Dabur consolidated revenue grew 11.6% with India FMCG up 10.7% on 5.5% volume growth. Profitability lagged the top line across the sector: Emami consolidated PAT fell 1.9% YoY and standalone PAT fell about 25%, with gross margin down 520 bps to 65.8% and EBITDA margin down 200 bps to 20.4%; Dabur operating margin contracted 60 bps amid elevated input costs and inflation. Britannia's standalone PBT grew only about 4.5% and its current borrowings jumped to ₹2,439.52 Crore from ₹1,071.72 Crore with inventories up sharply, a working-capital and leverage watch item. Capital returns remained generous (Emami ₹5/share interim dividend plus a ₹281.24 Cr buyback; Britannia ₹2,172.22 Crore dividends paid in six months), and the key pending catalysts are the 13 Nov 2026 Emami record date and a cluster of 16–17 Nov investor conferences. Filing-level governance items (qualified auditor review at Emami, DRI seizure at United Spirits) add event risk to an otherwise constructive but margin-pressured sector setup.

6 high priority 12 medium 18 total filings
· daily

BSE Pharma Sector Regulatory Filings — November 05, 2026

Across the 16 filings for the BSE Pharma constituent stream (all dated 2026-11-05), the dominant theme is strong underlying operating momentum tempered by reporting noise from one-offs and prior-year base effects. Ipca Laboratories posted consolidated revenue up 14% YoY to ₹2,909.94 Cr and PAT up 33% YoY to ₹375.13 Cr, with standalone EBITDA margin expanding to 26.61% from 25.46%, while Abbott India grew revenue 11.0% YoY to ₹1,951.01 Cr and profit 9.2% YoY to ₹453.45 Cr. Glenmark is the key divergence: reported Q2 FY27 consolidated revenue fell 29.8% YoY to Rs. 42,473 million, but the company cites roughly 20% like-for-like growth and ~31% core North America growth once the prior-year ISB 2001 out-licensing income is excluded, so reported figures understate the underlying trend. Dr. Reddy's secured Brazilian ANVISA approval for generic semaglutide, a meaningful incremental-market catalyst in a ~USD 244.6 million segment. Several filings (Sun Pharma, Zydus, GSK, IPCA call audio, Abbott board outcome) are procedural intimations with little quantitative content, and Torrent's ₹3.12 Cr GST penalty is immaterial. Overall the stream reads as constructive for earnings quality, with the main caveats being margin pressure from opex growth at Abbott and Glenmark's concentration of revenue in a volatile North America franchise.

5 high priority 11 medium 16 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — November 05, 2026

Across the four filings, two companies are in scope: Lodha Developers (a strong H1 FY27 with PAT of ₹2,386 Cr, +63% YoY, and revenue of ₹9,460 Cr, +30% YoY, against 7% pre-sales growth) and Prestige Estates Projects (three filings covering the Q2 FY27 quarter ended 30 Sep 2026). Prestige shows a sharp divergence between standalone and consolidated results: standalone revenue fell 16.7% YoY to Rs. 6,645 Mn while standalone profit rose 40.3% to Rs. 282 Mn, and consolidated revenue fell 15.3% to Rs. 20,602 Mn with consolidated net profit down 44.0% to Rs. 2,562 Mn. Consolidated inventories rose 14.0% QoQ to Rs. 4,58,677 Mn, a balance-sheet build that warrants monitoring for future cash conversion risk. Sentiment is mixed for both in-scope names, with Lodha's guidance-beat confidence offset by NRI demand softness from the Middle East conflict and rate sensitivity in the ₹1-5 Cr segment. The Prestige CPPIB investment in PHVL (up to Rs. 30,000 Mn, first tranche of Rs. 9,500 Mn secondary plus Rs. 5,500 Mn CCPS subscription in October 2026) and the withdrawal of the PHVL IPO DRHP are the most material capital-allocation developments in the set. The Prestige investor-presentation notice contains no figures and adds limited analytical value beyond confirming the reporting timeline. Overall the realty cohort shows strong profit momentum at Lodha and top-line contraction with margin and inventory pressure at Prestige.

2 high priority 2 medium 4 total filings
· daily

BSE IT Technology Sector Regulatory Filings — November 05, 2026

The 9 filings cover four S&P BSE IT constituents: Sonata Software (6 filings, dominant), Hexaware Technologies (2 filings), Happiest Minds Technologies (1 filing), and L&T Technology Services (1 administrative filing). Sonata's Q2 FY27 picture is mixed: consolidated revenue rose 15.4% YoY to Rs 2,445 Cr but fell 25.4% QoQ as Domestic Products & Services dropped 33.9% QoQ, while International IT Services grew 2.7% QoQ and 9.3% YoY. Standalone reported profit (Rs 19,019 lakh) was flattered by Rs 16,417 lakh of other income, mainly Rs 15,046 lakh of subsidiary dividends, so core operating earnings are considerably weaker. Balance sheet quality is a concern, with standalone trade receivables up 11.9% since March 2026 and H1 operating cash flow of only Rs 2,300 lakh. Hexaware reported Q3 CY26 revenue of $411.9M (+1.6% QoQ, +4.3% YoY) with adjusted EBIT margin of 13.8%, but withheld Q4 guidance pending a 90-day review by new CEO Vivek Jetley, while narrowing FY adjusted EBIT margin guidance to 13%–13.5%. Positive offsets include the five-year EBRD AI partnership for Hexaware and Happiest Minds' Rs 3.05 interim dividend. Overall the IT services sector shows steady international demand with domestic and non-core lines under pressure.

4 high priority 5 medium 9 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — November 05, 2026

Across the 27 filings for the BSE SENSEX 30 stream, the dominant theme is a strong headline Q2 FY27 earnings season led by Mahindra & Mahindra (consolidated revenue +25% YoY to ₹57,515 Cr, PAT ₹4,588 Cr, +25% YoY) and Titan (Total Income +25% YoY, PBT +53% YoY but flattered by ₹536 Cr of custom duty gains; ex-gains PBT +18%). Beneath the headlines, quality is mixed: M&M's Farm segment PAT fell 9% YoY and standalone Farm PBIT margin contracted 300 bps, while M&M's consolidated operating margin compressed to 13.42% from 14.22%, and Q1-to-Q2 sequential PAT softened. Bharti Airtel posted revenue +16.7% YoY to ₹60,878 Cr and EBITDA +17.8%, but Digital TV (+2.4%) and passive infrastructure (+4.0%) lagged, standalone profit was propped up by ₹3,073 Cr of other income, and net debt excluding leases rose 7.9% QoQ. The most material strategic development is Adani Ports' agreement to acquire 100% of Evos B.V. for an enterprise value of €2.56 bn (56% EBITDA margin, 28 ports/terminals across 10 countries post-deal, close expected within 15 months). Governance and capital-structure items (Bajaj Finance warrant pricing on 10 Nov, Titan auditor rotation and Noel Tata's retirement effective 12 Nov, Bharti's rights-issue fund deployment with ₹50,255 Mn of corporate-purpose money unutilized) add watch-list relevance. Market implication: earnings momentum is real but increasingly reliant on non-operating items and festive-calendar timing, so investors should differentiate reported from underlying growth.

8 high priority 19 medium 27 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — November 04, 2026

Across the five BSE BANKEX-linked filings dated 4 November 2026, the dominant development is Bank of Baroda's Q2 FY27 analyst meet, which reported record operating profit of INR 11,430 crore (up 50.9% YoY) and record net profit of INR 6,532 crore (up 35.8% YoY), but the headline quality is mixed: about INR 1,340 crore came from the NSE stake sale and valuation gains, and about INR 1,600 crore of prudential provisions lifted credit cost to 55 bps (18 bps ex-prudential). Underlying operating profit excluding one-offs was still a robust INR 7,749 crore. Management upsized FY27 credit growth guidance to 13-15% and deposit growth to 11-13%, held NIM at 2.75-2.95% and ROE at 15-16%, and signalled upward NIM movement in Q3 and Q4. The other four filings are governance and compliance items with no financial data: a Central Government nominee director at Union Bank of India, a RBI approval for Axis Bank's Executive Director re-appointment (shareholder approval still pending), a Kotak Mahindra physical-securities transfer window, and a State Bank of India market update rated low risk. Portfolio-level implication: sector governance flow is orderly, while earnings-quality scrutiny centres on Bank of Baroda's one-off dependence and FCNR(B)-driven growth.

5 medium 5 total filings
· daily

BSE Metal Sector Regulatory Filings — November 04, 2026

Six filings were reviewed for the India BSE METAL stream dated 4 November 2026; all six companies (Vedanta, National Aluminium, Lloyds Metals, Hindustan Zinc, Hindalco) sit within the S&P BSE METAL constituent scope, so none were excluded. The filings are predominantly administrative and governance-oriented: an ESOS vesting intimation at Vedanta, an earnings-call recording notice at Lloyds, a postal ballot advertisement at Hindustan Zinc, and an ESG rating disclosure at Hindalco. Because the enriched data supplied for these filings contains no period-over-period financial figures, forward guidance, insider transaction values, capital allocation amounts, or valuation details, portfolio-level margin or growth trends cannot be quantified from this batch. The most material item is Vedanta's vesting of 55,16,340 options (materiality 3/10), which is largely dilution-neutral at par exercise price and tied to demerger-related employee equity. Lloyds' Q2 and H1 FY27 earnings call is the most significant pending catalyst, though its numbers are not contained in the filing. Overall sentiment is uniformly neutral with low materiality, indicating a quiet session for the sector's disclosure stream.

6 medium 6 total filings
· daily

BSE Auto Sector Regulatory Filings — November 04, 2026

Across the 16 BSE AUTO filings dated 4 November 2026, the dominant theme is strong headline growth paired with margin and cash-flow pressure beneath the surface. Exide Industries, Apollo Tyres, TVS Motor, Balkrishna Industries, Schaeffler India and Mahindra & Mahindra all reported revenue growth in the high teens to mid-40s percent range YoY, yet several saw sequential or operating margin compression driven by raw material inflation, West Asia-linked energy costs and a weaker Rupee. Exide led on earnings momentum, with Q2 FY27 PAT up 75.1% YoY and EBITDA margin expanding to 12.1%, while Apollo Tyres showed the sharpest core deterioration, with operating margin falling from 14.94% to 10.73% and Europe segment results down roughly 46%. Balkrishna's operating margin fell to 11.77% and its debt-equity rose to 0.51x from 0.35x as borrowings climbed, and Schaeffler India's free cash flow dropped to INR 41 crore on working-capital build-up. TVS Motor's record quarter (revenue +44%, PAT +52%) and its proposed consumer-finance demerger are the most material corporate developments, but management guided to single-digit industry growth in Q3 on a high base. Overall the sector shows robust top-line demand with rising cost and working-capital strain, making margin recovery and cash conversion the key items to track.

8 high priority 8 medium 16 total filings
· daily

BSE FMCG Sector Regulatory Filings — November 04, 2026

The 22 filings are dominated by Dabur India (13 filings) and Hindustan Unilever (3), with Varun Beverages, Godrej Consumer Products, ITC, Britannia and Radico Khaitan providing the rest. Growth is strong on the headline: Dabur reported Q2 FY27 consolidated revenue of Rs 3,563 Cr (+11.6% YoY, but -5.3% QoQ) and PAT of Rs 505 Cr (+11.7% YoY), with an interim dividend of Rs 3.50/share (record date 10 Nov 2026). HUL posted 15% USG and 7% UVG, its strongest USG in 14 quarters, yet reported PAT was flat YoY and gross margin contracted roughly 400 bps. Varun Beverages showed 33.2% revenue growth but gross margin fell 334 bps YoY to 53.1% on packaging inflation, with management calling Q3 CY2026 the likely margin trough. Godrej Consumer grew consolidated revenue 19% but flagged a softer Personal Care segment and higher Q3 commodity inflation. The dominant portfolio pattern is volume-light, price-led growth alongside input-cost pressure, with Dabur's leadership transition the main governance development. No insider trading, pledge or buyback data was present in these filings.

5 high priority 17 medium 22 total filings
· daily

BSE Pharma Sector Regulatory Filings — November 04, 2026

Across the 44 filings for the S&P BSE PHARMA constituent set dated 4 November 2026, the dominant theme is a sharp divergence between top-line growth and bottom-line compression. Zydus Lifesciences (consolidated revenue +29% YoY to Rs 79,096 mn, PAT -26.6% to Rs 9,255 mn), Lupin (consolidated revenue +11.1% but PAT -22.2%, EBITDA margin down ~770 bps to 27.9%), Biocon (consolidated profit -57% YoY on +2% revenue) and Apollo Hospitals (revenue +23%, PAT up on a consolidated basis but standalone other expenses +27.7%) all show revenue growth outpacing or disconnected from earnings. Margin compression is the common thread: Zydus EBITDA margin fell to 24.0% from 32.9%, Lupin to 25.1% from 31.3% (EBITDA-basis), and Biocon EBITDA margin to 20% from 22%. Management commentary points to US competition, loss of exclusivity (Lupin, Sun Pharma's lenalidomide erosion), currency headwinds (GSK India) and rising employee and finance costs. On the positive side, Aurobindo Pharma delivered record quarterly revenue of Rs 10,263 Cr (+23.9% YoY) and EBITDA margin of 21.0%, and declared a Rs 7 interim dividend, while Zydus completed the Sterling Biotech API acquisition. Sentiment across the set is predominantly mixed, and near-term catalysts include the Alkem results on 12 November, the Aurobindo dividend record date of 11 November, the Sun Pharma Organon closing in Q4 FY27, and Glenmark's ASH presentation on 12 December.

13 high priority 31 medium 44 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — November 04, 2026

Three filings dated 2026-11-04 from BSE Realty constituents were reviewed: two Lodha Developers Limited disclosures (a routine ESOP share allotment of 56,654 shares and an Regulation 30 intimation of two investor conferences on Nov 17-18, 2026) and one Phoenix Mills Limited Q2/H1 FY27 earnings call transcript. The only substantive financial data comes from Phoenix Mills, where annuity revenue rose 16% YoY to Rs. 1,055 crore, annuity EBITDA grew 21% to Rs. 669 crore and annuity PAT before minority interest rose 31% to Rs. 391 crore, indicating strong recurring income momentum. Consolidated performance was weaker, with Q2 revenue of Rs. 1,153 crore and EBITDA of Rs. 710 crore held back by residential revenue recognition timing (H1 residential revenue only Rs. 62 crore). Retail consumption rose 25% YoY to Rs. 4,685 crore (22% excluding jewelry and electronics), though management flagged a 2-3% quarterly drag from fit-out activity on about 5% of leasable area. Balance-sheet movement was mixed: net debt rose Rs. 319 crore versus March 2026 but fell Rs. 179 crore versus June 2026. Lodha's filings contain no quantitative performance data and are low materiality (2/10), so the stream's near-term read-through rests mainly on Phoenix's office leasing ramp and FY27-28 rental guidance.

3 medium 3 total filings
· daily

BSE IT Technology Sector Regulatory Filings — November 04, 2026

Across the seven filings for the S&P BSE IT stream, the dominant themes are currency-flattered growth, a large debt financing tied to an European acquisition, and a steady flow of procedural investor-relations disclosures. Happiest Minds reported INR revenue up 12.5% YoY but USD revenue up only 3.6% and constant-currency growth of 6.8%, indicating that much of the headline expansion reflects rupee depreciation rather than underlying demand; operating margin nonetheless widened 100 bps QoQ to 18.5%. Persistent Systems' approval of INR 7,000 Cr of 8.95% secured NCDs in two series (2-year and 3-year maturities) signals a major balance-sheet commitment to finance the proposed Nagarro SE combination, shifting the investment case toward execution and leverage risk. TCS's Enterprise AI Study points to a gap between AI value realization and willingness to grant autonomy (only 10% allow agents to act without human approval), which tempers near-term AI-led revenue expectations. Management access is active, with HCL Technologies scheduling three investor conferences from November 16-19, 2026, and Zensar's Q2FY27 call transcript now published. The most material developments are the Persistent financing and the Happiest Minds ITC Infotech combination, both of which carry market-implication weight beyond the quarterly numbers.

7 medium 7 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — November 04, 2026

Across the 20 filings for the BSE SENSEX 30 stream dated 4 November 2026, the dominant theme is a sharp divergence between volume-led demand strength and margin pressure from input costs and currency. The clearest quantitative signal is IndiGo's Q2 FY27 call: total income rose 24% YoY to ₹243 billion and PRASK grew 31%, yet fuel CASK jumped 69% and the net loss narrowed only to ₹19 billion from ₹26 billion, with full-year CASK guidance now pointing to high-single to early-double-digit increases. Hindustan Unilever shows the same squeeze at the gross-margin line, with gross margin down roughly 400 bps and EBITDA margin down 140 bps to 22.6% even as USG hit 15%, its strongest in 14 quarters. Sun Pharma reported sales up 11.8% YoY but US sales down 8.2% on lenalidomide erosion and a slowing Ilumya, with the Organon deal still on track for Q4 FY27 closing. Governance and balance-sheet items were benign: Bajaj Finance's EGM approvals passed with over 99% in favour, Mahindra & Mahindra's AAA rating was reaffirmed with gearing of 0.09x, and Reliance's 'A-' rating was reaffirmed as Stable. The bulk of the remaining filings are administrative (RTA relocations, investor-conference notices, newspaper clippings) and carry no financial impact.

2 high priority 18 medium 20 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — November 03, 2026

Across the 11 filings, the BSE BANKEX stream is dominated by State Bank of India's Q2 FY27 results (quarter ended 30.09.2026), which show headline strength but weaker core earnings quality: standalone net profit rose 14.3% YoY to ₹23,038 Cr, yet this was flattered by a ₹7,288 Cr exceptional gain from divesting a 6.30% stake in SBI Funds Management, while operating profit before provisions fell 1.4% (standalone) and other income dropped 23.8% YoY. Asset quality improved across the board (GNPA 1.39% vs 1.73%, NNPA 0.36% vs 0.42%, provisions down 33% YoY to ₹2,759 Cr) and capital adequacy strengthened to 16.09%, but whole-bank NIM slipped 2 bps to 2.94%, cost-to-income rose 54 bps to 49.82%, and CASA ratio fell 131 bps to 38.32% with CASA growth (8.13%) lagging deposit growth (12.27%). Loan growth remains robust (gross advances +17.84% YoY), led by Foreign Offices, Agri, SME and retail, which is the main positive operating thread. Kotak Mahindra Bank's CCI approval for the Deutsche Bank India retail/private banking/wealth slump sale is the most significant strategic development, moving a major inorganic franchise closer to completion. The Canara Bank and Bank of Baroda filings are routine RTA-relocation notices, and the Axis Bank filing is a routine ESOP share allotment, so they carry little investment signal.

2 high priority 9 medium 11 total filings
· daily

BSE Metal Sector Regulatory Filings — November 03, 2026

Across the 19 filings for the S&P BSE METAL constituent stream, the dominant theme is strong year-over-year earnings growth coupled with sequential softening in Q2 FY27 versus Q1. Lloyds Metals and Energy dominates the filing count (9 of 19) and shows standalone total income up roughly 64% YoY and PAT up about 84% YoY, yet Q2 PAT fell about 27% QoQ and mining segment revenue collapsed about 56% QoQ, while leverage rose sharply (consolidated debt-equity 1.22, current ratio 0.82, debt service coverage 0.38). NALCO reported its best-ever H1 with total income up 33% YoY and an interim dividend of Rs 4.50 per share, but Q2 EBITDA and PAT both declined sequentially and production volumes fell YoY across bauxite, alumina hydrate and thermal power. Hindustan Zinc focused on product launches (VedAZ, VedAyush) and a Section 186 limit increase to Rs 30,000 crore, while Jindal Stainless' promoter entity added 0.06% via open-market buying, a constructive insider signal. Tata Steel's intra-group amalgamation with RIL is administrative with no cash or ownership impact. The portfolio-level read is that headline growth is robust but quality of earnings is uneven, with the most material risk concentrated in Lloyds' leverage and mining-segment volatility.

5 high priority 14 medium 19 total filings
· daily

BSE Auto Sector Regulatory Filings — November 03, 2026

Across the 12 BSE AUTO filings dated 3 November 2026, the dominant theme is a strong top-line recovery in two-wheelers and premium/EV segments paired with margin pressure from commodity inflation. Hero MotoCorp is the clearest data point: standalone revenue rose 21% YoY to INR14,687 crore and consolidated PAT jumped 41%, but the gain was flattered by a INR397 crore one-time associate QIP gain, and EBITDA margin (13.4%) remains below its 14-16% corridor. Bajaj Mobility AG (Bajaj Auto's step-down subsidiary) showed the strongest growth in the batch, with group revenue up 57.0% YoY to EUR 351.1 million and EBITDA turning positive, though a 3.2% EBIT margin signals that restructuring is not yet complete. Export and international expansion is a shared thread: TVS is targeting 30%+ of revenue from international markets by 2030 and Italy sales rose 110%, while Royal Enfield and Hero are launching premium and EV products at EICMA 2026. Most of the remaining filings are administrative (RTA office relocations, trading-window and board-meeting intimations), so the actionable signal is concentrated in roughly five filings. Near-term catalysts are the Balkrishna board meeting and possible 2nd interim dividend (4 November, record date 11 November), the Ashok Leyland results board meeting (14 November), and the Apollo Tyres Q2FY27 call rescheduled to 11:00 AM IST on 5 November.

1 high priority 11 medium 12 total filings
· daily

BSE FMCG Sector Regulatory Filings — November 03, 2026

Three BSE FMCG-constituent filings were published on 3 November 2026: Marico's Regulation 47 newspaper-publication notice for Q2/H1 FY27, Dabur's record-date intimation for an interim dividend, and a detailed Radico Khaitan analyst-meet disclosure. Only Radico carries substantive quantitative content: record Q2 FY27 IMFL volume above 10 million cases (+7% YoY), revenue of Rs. 1,746 crore, and EBITDA of Rs. 356 crore at a 20.4% margin (up 462 bps YoY). Its Prestige & Above segment grew 36% YoY to a record 5.28 million cases, while Regular volumes fell about 15% on a high Andhra base and Maharashtra/Karnataka policy changes. Gross margin expanded 440 bps YoY but compressed 109 bps QoQ to 48.0% on grain inflation and about Rs. 27 crore of packaging costs. Marico's and Dabur's filings contain no figures, so their results and dividend quantum cannot be assessed from these documents. The market-relevant near-term event is Dabur's board meeting on 4 November 2026, which will determine whether the 10 November record date takes effect. Overall, the theme is premiumisation offsetting mass-segment weakness and input-cost pressure within the sector.

3 medium 3 total filings
· daily

BSE Pharma Sector Regulatory Filings — November 03, 2026

Across the 11 filings for the S&P BSE PHARMA constituent stream, the dominant theme is strong headline top-line growth among large-cap pharma names, tempered by quality-of-earnings concerns. GSK Pharmaceuticals dominates the filings (five of eleven) and shows standalone Q2 FY27 revenue up ~21% YoY to Rs 117,991 lakh and profit up ~31-36% YoY, but a Rs 4,209 lakh one-time tax refund interest item flatters profit, cash fell from Rs 106,582 lakh to Rs 65,019 lakh after Rs 96,993 lakh of dividends, and inventories and receivables rose. Pfizer Limited delivered Q2 revenue up 11.3% YoY to Rs 726.86 Cr, but its 53% net profit jump was driven by a Rs 132.06 Cr exceptional item, with pre-exceptional PBT up only 5.1% and expenses growing faster than revenue (14.7%). Cipla's filing is largely administrative, but its consolidated half-year profit trend (down 11.3% YoY per the extract) contrasts with strong standalone income growth, signalling uneven group performance. Lupin's US launch of Raltegravir (first-to-file, 180-day exclusivity, ~USD 26M reference market) and GSK India's BLENREP launch are the clearest pipeline-driven catalysts, while Alkem's CEO appointment and Mankind's investor meet are governance and communications events with limited near-term financial impact. Net read: quality of growth, not growth itself, is the key diligence point across the group.

4 high priority 7 medium 11 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — November 03, 2026

This stream contains a single filing: Prestige Estates Projects Limited's cash acquisition of 100% of Gloind Vintage Infra Private Limited through its subsidiary PRVL, at a gross enterprise value of approximately INR 519 crores, closing on or before November 12, 2026. The deal is a mixed signal: it is an acquisition of a newly incorporated shell (Gloind, incorporated April 3, 2025, with nil FY 2025-26 turnover) whose valuation rests largely on the net worth of its subsidiary Tarun Realtors (INR 819.03 Million). Tarun Realtors' turnover fell about 46% in FY 2025-26 to INR 0.81 Million from INR 1.49 Million, after an 11% rise in FY 2024-25, so the acquired operating earnings base is shrinking while the price is substantial. The transaction is not a related party deal and no regulatory approvals are listed, which limits execution risk. For investors, the key points are the valuation premium relative to the target's current revenue and the strategic rationale for paying for land or development rights that the filing does not detail. Within the BSE Realty stream, this is a single-company read-through, so no sector-wide trend can be confirmed from this filing alone.

1 high priority 1 total filings
· daily

BSE IT Technology Sector Regulatory Filings — November 03, 2026

Across the four BSE IT constituent filings for the 2026-11-03 window, the only substantive financial disclosure is NIIT Limited's Q2 FY27 results, which show revenue of INR982 million, down 6% YoY but up 3% QoQ, and H1 FY27 revenue of INR1,939 million up 3% YoY, below management's earlier projections. The core weakness is concentrated in GSI-linked consumption, where four large clients pulled back by roughly INR100 million YoY, while Enterprise BIPS hit an all-time high of INR200 million (+17% YoY, +66% QoQ). EBITDA turned positive at INR27 million (2.7% margin) versus INR13.5 million a year ago, but the company swung to a net loss of INR22 million (EPS -INR0.16) from a PAT of INR14 million, and management guided FY27 revenue broadly flat with GSI volumes under pressure for two more quarters. The remaining three filings (Cyient registrar address change, Happiest Minds earnings-call audio upload, and Coforge's BridgeCX product launch) are administrative or qualitative and carry no period comparisons, forward guidance, insider activity, or capital allocation data, so they do not move the financial picture. Portfolio-level read: the IT services theme remains one of mix shift and collection-timing noise rather than broad demand breakdown, but NIIT's guidance implies no near-term growth catalyst from its largest client cohort.

4 medium 4 total filings